EFFICACY AND SAFETY OF THE USE OF CETUXIMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Croci, A. [1 ]
Aleman, A. [1 ]
Perez Galan, A. [1 ]
机构：
[1] Minist Publ Hlth, Montevideo, Uruguay
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.230
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN2
引用
收藏
页码：A815 / A815
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of short cetuximab infusion for patients with metastatic colorectal cancer
    Alshammari, K.
    Alanazi, R.
    Ali, M. Mohamed
    Abushara, A.
    Al-Abdulaali, A.
    Alotaibi, F.
    Shehata, H.
    Alkaiyat, M.
    Al Qahtani, J.
    Alolayan, A.
    Algarni, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S141 - S141
  • [2] Safety and efficacy of biweekly cetuximab based chemotherapy for patients with metastatic colorectal cancer
    Zekri, J.
    Farag, K.
    Haggag, R.
    ANNALS OF ONCOLOGY, 2016, 27 : 88 - 88
  • [3] An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative Review
    Giulia Fornasier
    Sara Francescon
    Paolo Baldo
    Advances in Therapy, 2018, 35 : 1497 - 1509
  • [4] An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative Review
    Fornasier, Giulia
    Francescon, Sara
    Baldo, Paolo
    ADVANCES IN THERAPY, 2018, 35 (10) : 1497 - 1509
  • [5] Efficacy and Safety of Maintenance Therapy Using Cetuximab in Patients with Metastatic Colorectal Cancer: Retrospective Study
    Xuan, Tiantian
    Wang, Zhanmei
    Meng, Sibo
    Li, Jiaxin
    Li, Jisheng
    Cao, Fangli
    Qu, Linli
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 185 - 197
  • [6] Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer
    Bouchahda, M.
    Macarulla, T.
    Spano, J. P.
    Bachet, J. B.
    Lledo, G.
    Andre, T.
    Landi, B.
    Tabernero, J.
    Karaboue, A.
    Domont, J.
    Levi, F.
    Rougier, P.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 67 (03) : 255 - 262
  • [7] Safety and efficacy of the addition of simvastatin to cetuximab in KRAS mutant metastatic colorectal cancer patients.
    Baas, Jara M.
    Krens, Lisanne
    Ten Tije, Albert J.
    Erdkamp, Frans
    Guchelaar, Henk-Jan
    Gelderblom, Hans
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Drug use evaluation of cetuximab in patients with metastatic colorectal cancer
    Josep Carreras, Maria
    Parera, Marta
    Padulles, Nuria
    Tomas, Elena
    Tabernero, Josep
    Monterde, Josep
    PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 137 - 138
  • [9] Evolution of efficacy and safety of cetuximab with the determination of RAS status in Metastatic Colorectal Cancer (mCRC) elderly patients
    Metges, J. -P.
    Capitain, O.
    Jean, F. Ramee
    Jean, L. Raoul
    Douillard, J. -Y.
    Pierre, L. Etienne
    Cumin, I.
    Dupuis, O.
    Faroux, R.
    Coulon, M. -A.
    Deguiral, P.
    Le Rol, A.
    Nacr, E. Achour
    Gorlaouen, A.
    Bouret, J. -F.
    Marhuenda, F.
    Lagadec, D. Deniel
    Grude, F.
    ANNALS OF ONCOLOGY, 2016, 27 : 40 - 40
  • [10] Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients
    Baas, J. M.
    Krens, L. L.
    ten Tije, A. J.
    Erdkamp, F.
    van Wezel, T.
    Morreau, H.
    Gelderblom, H.
    Guchelaar, H. J.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (06) : 1242 - 1247
12345